In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Editas Medicine, Inc.. Trade Record

NASDAQ:EDIT Editas Medicine, Inc. stock gains 22.79% Exit Feb 27, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart EDIT Feb 14, 2017, priceSeries
About Editas Medicine, Inc.

Developing gene editing therapies based on CRISPR/Cas9 technology.

Trade Information
Trade Type
LONG
ReliabilityScore™
90.91
Entry Date
Feb 14, 2017
Entry Price
18.86
Sell Date
Feb 27, 2017
Sell Price
23.16
Net Gain
22.79%
Hold Time
8 Trading Days